Cullen Capital Management, LLC reports 4.85% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Cullen Capital Management, LLC
Latest Disclosed Ownership	1,119,669 shares
Latest Disclosed Value	$ 67,907,923

On May 15, 2026 - Cullen Capital Management, LLC filed a 13F-HR form disclosing ownership of 1,119,669 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $58,693,049 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,176,726 shares of Bristol-Myers Squibb Company. This represents a change in shares of -4.85% during the quarter. The current value of the position is $53,105,901 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	Bristol-Myers Squibb	COM	110122108	1,119,669	-57,057	-4.85	67,908	6.99	0.6963
2026-02-13	2025-12-31	13F	Bristol-Myers Squibb	COM	110122108	1,176,726	-164,121	-12.24	63,473	4.96	0.6932
2025-11-05	2025-09-30	13F	Bristol-Myers Squibb	COM	110122108	1,340,847	79,777	6.33	60,472	3.59	0.6615
2025-09-30	2025-06-30	13F	Bristol-Myers Squibb	COM	110122108	1,261,070	142,481	12.74	58,375	-14.44	0.6647
2025-05-15	2025-03-31	13F	Bristol-Myers Squibb	COM	110122108	1,118,589	-47,588	-4.08	68,223	3.43	0.7881
2025-02-13	2024-12-31	13F	Bristol-Myers Squibb	COM	110122108	1,166,177	-144,826	-11.05	65,959	-2.76	0.7683
2024-11-12	2024-09-30	13F	Bristol-Myers Squibb	COM	110122108	1,311,003	-175,866	-11.83	67,831	9.85	0.7384
2024-08-13	2024-06-30	13F	Bristol-Myers Squibb	COM	110122108	1,486,869	220,358	17.40	61,750	-10.09	0.7112
2024-05-15	2024-03-31	13F	Bristol-Myers Squibb	COM	110122108	1,266,511	134,460	11.88	68,683	18.24	0.7646
2024-02-14	2023-12-31	13F	Bristol-Myers Squibb	COM	110122108	1,132,051	80,760	7.68	58,086	-4.80	0.8615
2023-11-14	2023-09-30	13F	Bristol-Myers Squibb	COM	110122108	1,051,291	1,785	0.17	61,017	-9.09	0.7123
2023-08-15	2023-06-30	13F	Bristol-Myers Squibb	COM	110122108	1,049,506	105,310	11.15	67,116	2.56	0.5992
2023-05-15	2023-03-31	13F	Bristol-Myers Squibb	COM	110122108	944,196	292,065	44.79	65,442	39.48	0.5988
2023-02-16	2022-12-31	13F	Bristol-Myers Squibb	COM	110122108	652,131	-168,213	-20.51	46,921	-19.54	0.6022
2022-11-10	2022-09-30	13F	Bristol-Myers Squibb	COM	110122108	820,344	48,133	6.23	58,318	-1.92	0.6248
2022-08-11	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	772,211	93,820	13.83	59,460	20.02	0.5971
2022-05-03	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	678,391	64,311	10.47	49,543	29.40	0.4561
2022-02-10	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	614,080	64,717	11.78	38,288	17.79	0.3589
2021-11-05	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	549,363	28,034	5.38	32,506	-6.69	0.3194
2021-08-04	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	521,329	38,306	7.93	34,835	14.24	0.3368
2021-05-10	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	483,023	396,688	459.48	30,493	469.43	0.3295
2021-01-26	2020-12-31	13F	Bristol-Myers Squibb	COM	110122108	86,335	71,915	498.72	5,355	516.23	0.2974
2020-11-02	2020-09-30	13F	Bristol-Myers Squibb	COM	110122108	14,420	0	0.00	869	2.48	0.0503
2020-07-31	2020-06-30	13F	Bristol-Myers Squibb	COM	110122108	14,420	-3,815	-20.92	848	-16.54	0.0477
2020-05-13	2020-03-31	13F/A-1	Bristol-Myers Squibb	COM	110122108	18,235	0	0.00	1,016	-13.24	0.0586
2020-05-05	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	118,815	100,580		6,623		161,171.4338
2020-01-31	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	18,235	-6,095	-25.05	1,171	-5.11	0.0459
2019-11-15	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	24,330	24,330		1,234		0.0495

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.